InfraScan receives 2022 Life Sciences PA Patient Impact Award
InfraScan receives the Life Sciences PA Patient Impact Award for the second time.
PHILADELPHIA, March 22, 2023 /PRNewswire-PRWeb/ -- InfraScan, a medical device firm specializing in traumatic brain injury diagnostic products, announces that the company has been named as one of the honorees for the Life Sciences PA Patient Impact Award for 2022: https://www.youtube.com/watch?v=Tq-MAIzydO4&feature=youtu.be.
The Life Sciences PA Patient Impact Award recognizes a medicine, therapy, device, or organization that has significantly contributed to the quality of healthcare or length of life of patients in 2022. A panel of independent judges selected InfraScan for receiving FDA clearance for the first hand-held diagnostic device for traumatic brain hemorrhage in children. This is the second time InfraScan has won the patient award.
"We are thrilled that InfraScan has been named as an honoree for this prestigious award," said InfraScan said Baruch Ben Dor, Ph.D. President and CEO of InfraScan. "Our company continues to grow, which underscores the valuable entrepreneurial contribution the company has made in traumatic brain injury technology, to patients, our employees, and customers."
The awards will be announced at the Annual Awards Dinner on May 3, 2023, and celebrated at the Annual Awards Tailgate on Tuesday, May 9, 2023, 3:00 PM — 6:00 PM EDT in King of Prussia, PA. The tailgate is an opportunity for guests from across the thriving Pennsylvania life sciences community to gather and celebrate with the annual award winners.
InfraScan has over 1,000 devices deployed in the US and internationally, including with some of the world's leading neurotrauma and trauma experts. InfraScan also licensed various patents that apply to hemorrhagic and ischemic stroke detection and brain hemorrhage monitoring.
About Life Sciences Pennsylvania
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania
About InfraScan, Inc.
InfraScan, Inc. is a medical device company that focuses on developing, commercializing, and distributing portable brain scanners for head injury and stroke assessment based on near-infrared (NIR) technologies. The company has received funding from the U.S. Army Medical Materiel Development Activity, U.S. Marine Corps, Office of Naval Research, BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, Ben Franklin Technology Partners of Southeastern Pennsylvania, and from the Philadelphia Industrial Development Corporation. For more information visit http://www.infrascanner.com and follow us @infrascanner.
Media Contact
David Clarke, Infrascan, Inc, 1 603-566-5149, [email protected]
SOURCE Infrascan, Inc
Share this article